Antacid-induced osteomalacia and nephrolithiasis
- 1 June 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (6) , 1007-1009
- https://doi.org/10.1001/archinte.138.6.1007
Abstract
A 36 yr old woman suffgred from bone pain, muscle weakness and renal stones after prolonged ingestion of antacids [aluminum-magnesium hydroxide] for esophageal reflux. Investigation disclosed hypophosphatemia, hypercalciuria and osteomalacia by bone biopsy. All symptoms and abnormal laboratory findings reversed with a regimen of oral phosphate supplementation and cessation of antacid intake.This publication has 8 references indexed in Scilit:
- The Importance of Phosphate in Regulating Plasma 1,25-(OH)2-Vitamin D Levels in Humans: Studies in Healthy Subjects, in Calcium-Stone Formers and in Patients with Primary Hyperparathyroidism*Journal of Clinical Endocrinology & Metabolism, 1977
- The pathophysiology and clinical characteristics of severe hypophosphatemiaArchives of internal medicine (1960), 1977
- Dietary Phosphate Deprivation in Women and Men: Effects on Mineral and Acid Balances, Parathyroid Hormone and the Metabolism of 25-OH-Vitamin D*Journal of Clinical Endocrinology & Metabolism, 1976
- Control of renal vitamin D hydroxylases in birds by sex hormones.Proceedings of the National Academy of Sciences, 1976
- PERSISTENT HYPOPHOSPHATÆMIA AND OSTEOMALACIA IN DIALYSIS PATIENTS NOT ON ORAL PHOSPHATE-BINDERS: RESPONSE TO DIHYDROTACHYSTEROL THERAPYThe Lancet, 1976
- Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion.Journal of Biological Chemistry, 1976
- Evidence for a Phosphorus-Depletion Syndrome in ManNew England Journal of Medicine, 1968
- Recent Progress in Osteomalacia and RicketsAnnals of Internal Medicine, 1967